Luis Iglesias has been promoted as Santen’s EMEA head, a move that sees him succeed Shigeo Taniuchi – who returns to Japan to become president and chief operating office of parent company Santen Pharmaceutical.
Iglesias initially joined Santen in 2017 as its senior vice president, commercial EMEA and brought with him more than 25 years’ experience in pharmaceuticals in Europe and the US.
He said: “I am honoured to accept this role and I look forward to working with my wonderful colleagues as we directly contribute to the achievement of our long-term strategic vision to become a specialised ophthalmology company with a global presence.”